Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Melatonin study

This article was originally published in The Tan Sheet

Executive Summary

"There is no evidence that melatonin is effective in treating secondary sleep disorders or sleep disorders accompanying sleep restrictions, such as jet lag and shift work disorder," a meta-analysis published in the British Medical Journal Feb. 18 finds. Nina Buscemi, University of Alberta, et al., analyzed 34 studies dated from 1999 to 2003 to rate the efficacy and safety of melatonin. Six trials with 97 participants showed no evidence that melatonin affects sleep onset latency in people with secondary sleep disorders. Nine trials with 427 patients showed no evidence that melatonin had an effect on sleep onset latency in people who had sleep disorders accompanying sleep restriction, and 17 trials with 651 participants showed no evidence of adverse effects in short term use of three months or less, Buscemi et al. report...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099177

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel